This protocol is judged by an institutional critique board, an unbiased team that evaluations any scientific trials involving people. If a research consists of a Routine I drug, once the board approves the protocol as ethical, the researchers need to make an application for an investigational new drug (IND) selection through the FDA.Access to unla